Since miR-145 normally increases myocardin, low levels observed in our study in VSMC in animals with CKD in vitro and in vivo, and in the circulation of patients with CKD may imply that the normal ‘safeguard’ regulation of myocardin by miR-145 may be impaired. The gene discussed is MYOCD; the disease is chronic kidney disease.